Cognitive and behavioral improvement in adults with fragile X syndrome treated with metformin‐two cases

Metformin for Treatment of Fragile X Syndrome and Other Neurological Disorders

(2018) Ilse Gantois et al.   Annual Review of Medicine

Prevention of cognitive impairment: scientific guidance and windows of opportunity

(2017) Philip B. Gorelick   JOURNAL OF NEUROCHEMISTRY

Metformin ameliorates core deficits in a mouse model of fragile X syndrome

(2017) Ilse Gantois et al.   NATURE MEDICINE

Fragile X syndrome

(2017) Randi J. Hagerman et al.   Nature Reviews Disease Primers

Insulin signaling misregulation underlies circadian and cognitive deficits in a Drosophila fragile X model

(2016) R E Monyak et al.   MOLECULAR PSYCHIATRY

Metformin: From Mechanisms of Action to Therapies

(2014) Marc Foretz et al.   Cell Metabolism

High MMP-9 activity levels in fragile X syndrome are lowered by minocycline

(2013) Magdalena Dziembowska et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

Fragile X syndrome: An aging perspective

(2013) Andrea Schneider et al.   Developmental Disabilities Research Reviews

Fragile X Syndrome

(2012) Yingratana McLennan et al.   CURRENT GENOMICS

Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome

(2012) C. A. Hoeffer et al.   GENES BRAIN AND BEHAVIOR

Cellular and molecular mechanisms of metformin: an overview

(2011) Benoit Viollet et al.   CLINICAL SCIENCE

Metformin for Obesity in Children and Adolescents: A Systematic Review

(2009) M. H. Park et al.   DIABETES CARE